Mereo BioPharma Group

NASDAQ: MREO · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 06:25 PM EDT

Mereo BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-43.25M -29.47M -36.09M 14.24M
Depreciation & Amortization
1.09M 1.06M 727K 642K
Stock-Based Compensation
7.39M 4.92M 4.77M 4.46M
Other Working Capital
-515K -786K 1.13M -1.26M
Other Non-Cash Items
2.31M 3.94M -9.14M 13.41M
Deferred Income Tax
n/a n/a n/a -34.99M
Change in Working Capital
-369K -1.59M 1.82M -1.84M
Operating Cash Flow
-32.83M -21.13M -38.82M -5.24M
Capital Expenditures
-699K -419K -10K -535K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-699K -419K 1.51M 114K
Investing Cash Flow
-699K -419K 1.5M -421K
Debt Repayment
n/a -3.19M -1.13M -933.95K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 24K 349.96K -253.73K
Financial Cash Flow
46.15M 7.97M -784K 77.65M
Net Cash Flow
12.38M -10.76M -37.96M 70.83M
Free Cash Flow
-33.53M -21.55M -38.83M -5.77M